Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
JYNNEOS vaccine coverage remains highly variable across jurisdictions with low uptake of the second dosage, as of November 2023 data.News Article updated on 01/08/2024
-
HIV/HCV Viral Clearance Cascade Training Series
Mini-modules on the steps required to use available public health datasets to create and act upon HIV and hepatitis C viral clearance cascades.Resource updated 05/15/2024
-
Innovative HIV Care Strategies to Address HIV and STIs
This webinar features Addressing STIs: Ask. Test. Treat. Repeat., an intervention for people with HIV or those who are vulnerable to HIV acquisition.Resource updated 05/15/2024
-
Replicating Innovative HIV Care Strategies in the RWHAP
Webinar series featuring HIV care innovations developed under HRSA SPNS projects.Resource updated 04/02/2024
-
JumpstART
JumpstART launched in 2016 as part of New York State’s Ending the Epidemic initiative, changing the service delivery model of eight sexual health clinics to include an initial prescription of ART after an HIV diagnosis and prior to linkage to the community provider. Between November 2016 and September 2018, 60% of JumpstART clients received ART on the same day as diagnosis. JumpstART clients were also more likely to reach viral suppression within three months compared to non-JumpstART clients.Resource from the RWHAP Best Practices Compilation updated on 12/15/2023
-
Addressing STIs: Ask, Test, Treat, Repeat.
The Addressing STIs: Ask, Test, Treat, Repeat. intervention seeks to address the rising rates of sexually transmitted infections (STIs) in the United States over the past several years.Resource updated 05/15/2024
-
DISQ Office Hours: Gender-Affirming Data Collection
DISQ “Office Hours” are technical assistance opportunities that allow Ryan White HIV/AIDS Program (RWHAP) recipient and provider staff to talk with their peers in an informal setting about specific technical challenges and solutions. These hour-long calls include a short presentation by a RWHAP recipient or provider about their data management approach.
Resource updated 07/13/2023
-
Clinical Trial: New Gonorrhea Treatment Effective
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.News Article updated on 11/16/2023 -
Coordination of Supportive Employment and Housing Services
The intervention integrated supportive employment services, housing services, and HIV care for clients receiving case management services and with unmet housing and employment needs. Evaluation of the program showed improvements in employment rates, participant confidence in being able to hold onto a job, household median income, participants’ living situations, and self-perception of homelessness status.Resource from the RWHAP Best Practices Compilation updated on 04/29/2024
-
Is Medicare About to Cover PrEP Under Part B?
Is Medicare going to adopt the practice of private health insurance and start covering PrEP without cost-sharing under Part B?News Article updated on 05/14/2024 -
Leveraging a Data to Care Approach to Cure Hepatitis C within the RWHAP
SPNS initiative aimed to link individuals co-infected with HIV and HCV to care by leveraging public health surveillance and clinical data systems. Project period: 2020-2022.Resource updated 05/15/2024
-
Mpox Treatment Study Underway: How to Take Part
Insights on how to take part in the clinical trial are outlined in HIV.gov's Help Scientists Find a Safe and Effective Mpox Treatment.News Article updated on 05/17/2024 -
HAB Updates its Mpox Info
HRSA's HIV/AIDS Bureau has updated its mpox resources.News Article updated on 05/23/2024 -
HIV Prevention and Care Improvements Summarized in CDC Surveillance Reports
In the U.S., the number of new HIV cases continue to decline, most people are linked to care within one month of their HIV diagnosis, and 69% reach viral suppression within 6 months of HIV diagnosis.News Article updated on 06/10/2024 -
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
340B Drug Pricing Program
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
-
Clinical Info HIV.gov
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
-
Data Integration, Systems and Quality (DISQ) Team
Help with the RSR, ADR, CDR, EHE, HIVQM, and AETC data systems. Project period: 2020-2025.
RWHAP Technical Assistance Provider updated on 04/15/2024
-
CoRECT
CoRECT was a data to care project to identify and reengage people with HIV who were newly out of care. It included a clinic and health department data reconciliation process to identify missed laboratory results or appointments and create the out-of-care list, case discussions via telephone to review the combined list, and field epidemiologist outreach to assist clients with making appointments, securing transportation, and arranging referrals. The intervention employed strengths-based case management techniques and motivational interviewing to contact identified people within 30 days, reengage them in care, and reduce time to viral suppression.Resource from the RWHAP Best Practices Compilation updated on 03/19/2024
-
Stronger Together
Stronger Together uses counseling to increase engagement in and improve the quality of HIV care available for serodiscordant male couples. Through three in-person and additional “booster” sessions over an 18-month period, Stronger Together gave couples a space to work with an HIV professional to improve treatment adherence and keep both people healthy. Stronger Together participants were more likely to adhere to ART than those in a control group.Resource from the RWHAP Best Practices Compilation updated on 04/12/2024